Comparative Risk for Angioedema Associated With the Use of Drugs That Target the Renin-Angiotensin-Aldosterone System

This publication has 26 references indexed in Scilit:

• Analyzing partially missing confounder information in comparative effectiveness and safety research of therapeutics
  Pharmacoepidemiology and Drug Safety, 2012
• The U.S. Food and Drug Administration's Mini‐Sentinel program: status and direction
  Pharmacoepidemiology and Drug Safety, 2012
• A protocol for active surveillance of acute myocardial infarction in association with the use of a new antidiabetic pharmaceutical agent
  Pharmacoepidemiology and Drug Safety, 2012
• Design considerations, architecture, and use of the Mini‐Sentinel distributed data system
  Pharmacoepidemiology and Drug Safety, 2012
• A policy framework for public health uses of electronic health data
  Pharmacoepidemiology and Drug Safety, 2012
• The organizational structure and governing principles of the Food and Drug Administration's Mini‐Sentinel pilot program
  Pharmacoepidemiology and Drug Safety, 2012
• Updated Report on Comparative Effectiveness of ACE inhibitors, ARBs, and Direct Renin Inhibitors for Patients with Essential Hypertension: Much More Data, Little New Information
  Journal of General Internal Medicine, 2011
• Angioedema Incidence in US Veterans Initiating Angiotensin-Converting Enzyme Inhibitors
  Hypertension, 2008
• Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics
  Pharmacoepidemiology and Drug Safety, 2006
• Vaccines for preventing anthrax
  Cochrane Database of Systematic Reviews, 1998